Skip to content
Fiscal Receipts

Senate LDA lobbying filing

MCKESSON CORPATION AND ITS AFFILIATE US ONCOLOGY (FORMERLY US ONCOLOGY)

Registrant: STANTON PARK GROUP Year: 2025 Period: Third Quarter Type: Q3

View on lda.senate.gov ↗

Reported income

$60.0K

Reported expenses

not reported

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

Lobbying activities2

  • Health IssuesHCR

    H.R.2484, Seniors Access to Critical Medications Act of 2025

  • Medicare/MedicaidMMM

    Medicare, oncology, radiation and imaging reimbursement issues; medicare physician payments; Oncology payment disparities in Medicare.; Health information technology; application of the sequester to cancer drug reimbursement; prompt pay discount; safety and security of the prescription drug supply chain.

Lobbyists8

  • AISLING MCDONOUGHrevolving door

    Chief of Staff, Rep. Anna Eshoo; Senior Health Advisor, Rep. Anna Eshoo; Policy Coordinator, Energy & Commerce Committee; Legislative Assistant, Sen. Brian Schatz

  • BRYAN WELLSrevolving door

    Policy Advisor, Sen. Pat Roberts

  • BRYAN WELLSrevolving door

    Policy Advisor, Senator Pat Roberts

  • JAMES DERDERIAN
  • JAMES DERDERIANrevolving door

    Chief of Staff, House Commerce Committee; Legislative Advisor to Rep. Tom Bliley

  • JOSEPH RACHINSKY
  • VALERIE HENRY
  • VALERIE HENRYrevolving door

    Legislative Director, Rep. Greg Walden; Legislative Assistant to Sen. John Warner and Sen. Mike Crapo

Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.